Status and phase
Conditions
Treatments
About
This is a randomized, double-blind, multiple-site, placebo-controlled, parallel-group study, designed to compare the efficacy and safety of generic Clindamycin 1% gel (Akorn), and the marketed product Clindamycin 1% gel (Greenstone LLC) in the treatment of acne vulgaris.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
IInclusion Criteria:
Exclusion Criteria:
Primary purpose
Allocation
Interventional model
Masking
1,125 participants in 3 patient groups, including a placebo group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal